WallStreetZenWallStreetZen

NASDAQ: CBUS
Cibus Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CBUS

Based on 1 analyst offering 12 month price targets for Cibus Inc.
Min Forecast
$25.00+67.79%
Avg Forecast
$25.00+67.79%
Max Forecast
$25.00+67.79%

Should I buy or sell CBUS stock?

Based on 1 analyst offering ratings for Cibus Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CBUS stock forecasts and price targets.

CBUS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22

1 of 1

Forecast return on equity

Is CBUS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36%

Forecast return on assets

Is CBUS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CBUS revenue forecast

What is CBUS's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$1.9M+5.94%
Avg 2 year Forecast
$8.7M+378.26%
Avg 3 year Forecast
$45.2M+2,385.14%
CBUS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CBUS revenue growth forecast

How is CBUS forecast to perform vs Biotechnology companies and vs the US market?
Company
180.74%
Industry
38.03%
Market
10.06%
CBUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CBUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CBUS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CBUS$14.90$25.00+67.79%Buy
NKTX$7.29$18.80+157.89%Strong Buy
MNMD$8.68$38.25+340.67%Strong Buy
AURA$7.19$20.00+178.16%Strong Buy
RANI$7.07$9.67+36.73%Strong Buy
View Top Biotech Stocks

Cibus Stock Forecast FAQ

Is Cibus Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CBUS) stock is to Buy CBUS stock.

Out of 1 analyst, 0 (0%) are recommending CBUS as a Strong Buy, 1 (100%) are recommending CBUS as a Buy, 0 (0%) are recommending CBUS as a Hold, 0 (0%) are recommending CBUS as a Sell, and 0 (0%) are recommending CBUS as a Strong Sell.

If you're new to stock investing, here's how to buy Cibus stock.

What is CBUS's revenue growth forecast for 2024-2026?

(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 180.74% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Cibus's revenue in 2024 is $1,817,000.On average, 2 Wall Street analysts forecast CBUS's revenue for 2024 to be $46,454,117, with the lowest CBUS revenue forecast at $44,644,217, and the highest CBUS revenue forecast at $48,264,018. On average, 2 Wall Street analysts forecast CBUS's revenue for 2025 to be $209,707,158, with the lowest CBUS revenue forecast at $57,434,181, and the highest CBUS revenue forecast at $361,980,135.

In 2026, CBUS is forecast to generate $1,089,680,866 in revenue, with the lowest revenue forecast at $900,365,256 and the highest revenue forecast at $1,278,996,477.

What is CBUS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CBUS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CBUS's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CBUS price target, the average CBUS price target is $25.00, with the highest CBUS stock price forecast at $25.00 and the lowest CBUS stock price forecast at $25.00.

The Wall Street analyst predicted that Cibus's share price could reach $25.00 by Mar 22, 2025. The average Cibus stock price prediction forecasts a potential upside of 67.79% from the current CBUS share price of $14.90.

What is CBUS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CBUS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.